HomeCompaniesProfile

Engage Bio

mRNA Immunotherapies to Eliminate Cancer 


Company Size

1 - 5 employees

Year Founded

2021


About Engage Bio

Engage Bio is developing mRNA immunotherapies to defeat cancer. Our founders have deep experience in immunotherapy development, including four drugs in the clinic, and in building mRNA therapeutics platforms. Our approach is to provide cancer cells with instructions to make and gradually release our drugs within solid tumors. This local therapy allows us to eliminate tumors while sparing healthy distant tissues.

Founders & Key People

Will Olsen

Will Olsen

Founder, Engage Bio

Kathryn Kwant

Kathryn Kwant

Founder, Engage Bio

Share This Profile

More Companies

Correlia Biosystems

Next-gen blood testing to provide 1000x more data to pharma companies

Shaped

The fastest path to relevant recommendations and search

Dashworks

Your team's intelligent start page.

Warpdrive by Synthetic Minds

From screen recordings to desktop automations using program synthesis

Kobo360

Africa's leading supply chain technology platform.

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.